clinico-economical impact of hta implementation on chest pain diagnostic markers

9
Clinico-Economical Impact of HTA Implementation on chest pain diagnostic Marker Dott. Antonella Pugliese U.O. Education and Clinical Governance S.Camillo-Forlanini Hospital, Rome, Italy

Upload: htacamp

Post on 21-Jan-2015

469 views

Category:

Documents


0 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

Clinico-Economical Impact of HTA Implementation on chest pain diagnostic Marker

Dott . Antonella PuglieseU.O. Educati on and Clinical GovernanceS.Camillo-Forlanini Hospital, Rome, Italy

Page 2: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

WHY AN HTA ON CHEST PAIN DIAGNOSTIC MARKERS PRESCRIPTION?

TECHNOLOGY IMPROVEMENT GUIDELINE MODIFICATION

TROPONIN I and T

MAIN DIAGNOSTIC MARKERS OF CHEST PAIN:

CK-MBMYOGLOBIN

Page 3: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

METHODOLOGY OF TECHNOLOGY STUDYTroponin CK MB Myoglobin BNP CRP

Chest pain (probably heart related) X1

STEMI X2 X3

NSTEMI X2 X3

Acute instable angina X2 X3

Major trauma X

Reperfusion syndrome X

Myo - pericarditis X2 X3 X

Yes,It should be used

X3 = note

Technologies

No Indication

Clinical presentations

Page 4: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

S. Camillo- Forlanini U.O. Formazione e Governo Clinico

Troponin CK MB Myoglobin BNP CRP

Chest pain (probably heart related) X1

STEMI X2 X3

NSTEMI X2 X3

Acute instable angina X2 X3

Major trauma X

Reperfusion syndrome X

Myo - pericarditis X2 X3 X

METHODOLOGY OF TECHNOLOGY STUDY

Page 5: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

INTERVENTION OUTCOME GRAPHICS

JanuaryFebrauryM

archAprilM

ayJuneJulyAugustSeptem

berOctoberNovem

berDecem

ber

0

500

1000

1500

2000

FIRST AID REQUESTS NUMBER

MyoglobinCK-MBTroponin

Page 6: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

CLINICAL IMPACT VERIFICATION THROUGH STATISTICAL ANALYSIS

Admitted Not Admitted Total Accesses

After Intervention 539 1590 2129

Before Intervention 830 2487 3317

Total 1369 4077 5446

Confidence Level 99%

Value Confidence Interval 99%

Relative Risk (RR) 1,012 0,894 1,144

Absolute Risk Reduction -0,003 -0,034 0,028

Relative Risk Reduction -0,012 -0,144 0,106

CONFIDENCE INTERVAL CONTAINS

NUMBER ONE

NULL HYPOTESIS IS CONFIRMED

THERE IS NOT ANY DIFFERENCE

BETWEEN BEFORE AND AFTER THE INTERVENTION

Page 7: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

Myoglobin exams One Year Estimation One Year Cost

First Aid After intervention 444 1.621

Before intervention 13.816 50.428

Rest of the Hospital After intervention 581 2.120

Before intervention 18.076 65.977

Cost per kit (euro) Number of tests/

1 kitEffective tests Number /

1 KitReagent Cost or Single test Cost

Myoglobin 766 250 210 3,65

ECONOMICAL ANALYSIS

Page 8: Clinico-economical impact of HTA implementation on chest pain diagnostic markers

S. Camillo- Forlanini U.O. Formazione e Governo Clinico

We started from an average of about 1100 myoglobin / month / First Aid tests.The intervention led to an inappropriateness reduction of 96.78%.

First Aid Rest of the Hospital

Total Estimated Saving

48.808 + 63.857 = 112.665 EURO /Year

APPROPRIATENESS AND ECONOMICAL IMPACT